同种异体简易角膜缘上皮移植治疗持续性角膜上皮缺损
本文回顾性分析了14例(14眼)持续性角膜上皮缺损患者接受尸体供眼同种异体简易角膜缘上皮移植(alloSLET)的临床结局。术后3个月和6个月分别有92.9%的眼实现角膜表面上皮化,12个月时为71.4%;术后最佳矫正视力(BCVA)整体明显改善,但两个亚组分别分析时改善不显著。alloSLET可能是不具备自体角膜缘组织时的有效治疗选择。
要点
- 14眼中10眼(71.4%)在术后12个月维持角膜表面上皮化。
- 术后BCVA整体明显改善,但alloSLET单用组和联合PK组分别分析时改善不显著。
核心结论
- alloSLET对于无自体角膜缘组织可用的持续性角膜上皮缺损眼可能是一种有效的治疗选择。
研究设计与样本
- 回顾性病例系列,纳入14例(14眼)接受alloSLET治疗的持续性角膜上皮缺损患者,其中7眼仅行alloSLET,7眼行alloSLET联合穿透性角膜移植(PK)。
主要发现
- alloSLET单用组和联合PK组分别有5眼(71.4%)在术后12个月角膜上皮稳定。
- 术后BCVA在整体患者中明显改善,但在两个亚组分别分析时改善不显著。
- 1例患者术后第一个月内多次丢失绷带接触镜并出现羊膜部分脱离,该眼角膜表面未能上皮化。
- 3例患者角膜缘供体组织移位至角膜中央,可能延长了BCVA改善的时间。
临床怎么用
- 当自体角膜缘组织不可用时,可考虑使用尸体供眼的alloSLET治疗持续性角膜上皮缺损。
- 术后需关注绷带接触镜和羊膜稳定性,以及角膜缘供体组织移位情况。
局限性
- 回顾性研究,样本量小(14眼),未设对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIM: To describe the clinical outcome of allogenic simple limbal epithelial transplantation (alloSLET) utilising tissue from cadaveric donor eyes after failed re-epithelialisation of the corneal surface. METHODS: Medical records of 14 eyes from 14 patients treated for persistent corneal epithelial defects with alloSLET were reviewed. The primary outcome measure was complete epithelialisation of the corneal surface. Secondary outcome measures were best corrected visual acuity (BCVA) and postoperative side effects due to surgery or medical therapy. RESULTS: Of the 14 eyes, 7 received alloSLET only and 7 alloSLET together with penetrating keratoplasty (PK). Thirteen (92.9%) of 14 eyes had an epithelialised corneal surface 3 and 6 months after surgery and 10 (71.4%) of 14 eyes displayed an epithelialised corneal surface 12 months after surgery. In both subgroups, alloSLET only and alloSLET with PK, respectively, 5 (71.4%) of 7 eyes had a stable corneal epithelium 12 months after surgery, respectively. Postoperatively, BCVA improved markedly in the whole patient collective. However, the increase was not significant when looking at the two individual subgroups. One patient lost his bandage contact lens several times within the first postoperative month and had a partial detachment of the amniotic membrane. The ocular surface of this patient failed to epithelialise. In three patients, limbal donor pieces translocated to the centre of the cornea, which possibly prolonged the improvement of BCVA. CONCLUSION: AlloSLET appears to be an effective treatment option in eyes with non-healing corneal epithelial defects when autologous limbal tissue is not available.
引用
- Riedl JC, Musayeva A, Wasielica-Poslednik J, et al. Allogenic simple limbal epithelial transplantation (alloSLET) from cadaveric donor eyes in patients with persistent corneal epithelial defects. Br J Ophthalmol. 2020. PMID: 32327416. doi:10.1136/bjophthalmol-2019-315176
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。